Determinants of Late Supraventricular Arrhythmia After Patent Foramen Ovale Closure: Insights From a Prospective Cohort.

IF 5.8 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS
Louis Giovachini, Mikael Laredo, Marie Hauguel-Moreau, Michel Zeitouni, Thomas Rolland, Yassine Temmar, Delphine Brugier, Candice Sabben, Nefeli Valyraki, Sonia Alamowitch, Clemence Blanc, Niki Procopi, Anthony Elhadad, Gabriel Chevrot, Marie Dupuy, Arnaud Ferrante, Stéphanie Rouanet, Nadjib Hammoudi, Johanne Silvain, Gilles Montalescot, Paul Guedeney
{"title":"Determinants of Late Supraventricular Arrhythmia After Patent Foramen Ovale Closure: Insights From a Prospective Cohort.","authors":"Louis Giovachini, Mikael Laredo, Marie Hauguel-Moreau, Michel Zeitouni, Thomas Rolland, Yassine Temmar, Delphine Brugier, Candice Sabben, Nefeli Valyraki, Sonia Alamowitch, Clemence Blanc, Niki Procopi, Anthony Elhadad, Gabriel Chevrot, Marie Dupuy, Arnaud Ferrante, Stéphanie Rouanet, Nadjib Hammoudi, Johanne Silvain, Gilles Montalescot, Paul Guedeney","doi":"10.1016/j.cjca.2025.04.007","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Early (≤ 28 days) supraventricular arrhythmia (SVA) is the most common complication that occurs after patent foramen ovale (PFO) closure, but little is known about the incidence and determinants of late (> 28 days) SVA. Our aim was to evaluate the determinants of late SVA after PFO closure.</p><p><strong>Methods: </strong>Patients with percutaneous PFO closure and risk of SVA were proposed to receive an implantable loop recorder (ILR) device from 2019 to 2023. All rhythmic events recorded on ILR were adjudicated by cardiac electrophysiologists. Primary outcome was any late SVA, either new onset or recurrence, defined as SVA occurring > 28 days after PFO closure and lasting ≥ 30 seconds. Determinants were analyzed using a multivariable Cox proportional hazards model.</p><p><strong>Results: </strong>Overall, 234 patients were included with a median duration of ILR rhythm monitoring of 21.6 (interquartile range, 15.5-30.6) months. An SVA after 28 days was recorded in 50 of 234 patients (2-year Kaplan-Meier estimate, 0.22 [0.16-0.27]), which were recurrent events in 29 of 50 (58.0%) cases and new-onset episodes in 21 of 50 (42.0%) cases. Incidence of new onset of SVA decreased significantly over time. In the multivariate analysis, determinants of late SVA were the early SVA burden (adjusted hazard ratio [aHR], 1.008; 95% confidence interval [CI], 1.003-1.013 per hour of SVA occurring in the first 28 days), male sex (aHR, 2.29; 95% CI, 1.19-4.42), and large left disc diameter (aHR, 2.50; 95% CI, 1.32-4.72).</p><p><strong>Conclusions: </strong>Determinants of late SVA after PFO closure were SVA burden during the first month, male sex and large left disc diameter.</p>","PeriodicalId":9555,"journal":{"name":"Canadian Journal of Cardiology","volume":" ","pages":""},"PeriodicalIF":5.8000,"publicationDate":"2025-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Canadian Journal of Cardiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.cjca.2025.04.007","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Early (≤ 28 days) supraventricular arrhythmia (SVA) is the most common complication that occurs after patent foramen ovale (PFO) closure, but little is known about the incidence and determinants of late (> 28 days) SVA. Our aim was to evaluate the determinants of late SVA after PFO closure.

Methods: Patients with percutaneous PFO closure and risk of SVA were proposed to receive an implantable loop recorder (ILR) device from 2019 to 2023. All rhythmic events recorded on ILR were adjudicated by cardiac electrophysiologists. Primary outcome was any late SVA, either new onset or recurrence, defined as SVA occurring > 28 days after PFO closure and lasting ≥ 30 seconds. Determinants were analyzed using a multivariable Cox proportional hazards model.

Results: Overall, 234 patients were included with a median duration of ILR rhythm monitoring of 21.6 (interquartile range, 15.5-30.6) months. An SVA after 28 days was recorded in 50 of 234 patients (2-year Kaplan-Meier estimate, 0.22 [0.16-0.27]), which were recurrent events in 29 of 50 (58.0%) cases and new-onset episodes in 21 of 50 (42.0%) cases. Incidence of new onset of SVA decreased significantly over time. In the multivariate analysis, determinants of late SVA were the early SVA burden (adjusted hazard ratio [aHR], 1.008; 95% confidence interval [CI], 1.003-1.013 per hour of SVA occurring in the first 28 days), male sex (aHR, 2.29; 95% CI, 1.19-4.42), and large left disc diameter (aHR, 2.50; 95% CI, 1.32-4.72).

Conclusions: Determinants of late SVA after PFO closure were SVA burden during the first month, male sex and large left disc diameter.

卵圆孔未闭后晚期室上性心律失常的决定因素:来自前瞻性队列的见解。
背景:早期(≤28天)室上性心律失常(SVA)是卵圆孔未闭(PFO)术后最常见的并发症,但对晚期(> 28天)SVA的发生率和决定因素知之甚少。我们的目的是评估PFO关闭后晚期SVA的决定因素。方法:建议2019 - 2023年经皮PFO闭合且有SVA风险的患者接受植入式环路记录器(ILR)装置。ILR记录的所有节律事件均由心脏电生理学家判定。主要终点是任何晚期SVA,无论是新发还是复发,定义为SVA发生于PFO关闭后28天,持续时间≥30秒。采用多变量Cox比例风险模型分析决定因素。结果:总体而言,纳入234例患者,ILR节律监测的中位持续时间为21.6个月(四分位数范围为15.5-30.6个月)。234例患者中有50例(2年Kaplan-Meier估计值0.22[0.16-0.27])发生28天后SVA,其中29例(58.0%)为复发事件,21例(42.0%)为新发事件。随着时间的推移,新发SVA的发生率显著下降。在多因素分析中,晚期SVA的决定因素是早期SVA负担(校正风险比[aHR], 1.008;95%可信区间[CI],前28天SVA发生的每小时1.003-1.013),男性(aHR, 2.29;95% CI, 1.19-4.42)和大左椎间盘直径(aHR, 2.50;95% ci, 1.32-4.72)。结论:PFO关闭后晚期SVA的决定因素是第一个月的SVA负担,男性和大的左椎间盘直径。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Canadian Journal of Cardiology
Canadian Journal of Cardiology 医学-心血管系统
CiteScore
9.20
自引率
8.10%
发文量
546
审稿时长
32 days
期刊介绍: The Canadian Journal of Cardiology (CJC) is the official journal of the Canadian Cardiovascular Society (CCS). The CJC is a vehicle for the international dissemination of new knowledge in cardiology and cardiovascular science, particularly serving as the major venue for Canadian cardiovascular medicine.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信